Illumina · 4 days ago
Firmware Test Engineer 1
Illumina is a company focused on expanding access to genomic technology for health equity. They are seeking a Firmware Test Engineer 1 who will be responsible for triaging firmware issues, collaborating with engineers to build automated testing systems, and developing test specifications for FDA approved diagnostic instruments.
BiotechnologyGeneticsHealth CareMedical
Responsibilities
Triage instrument FW issues discovered by other teams, identify gaps in functional testing. Work with FW Team to reproduce problems, design and run tests to prove correction
Work collaboratively with other engineers to build an automated testing system
Work with EE team, software developers, scientists and domain experts in understanding requirements of the firmware and translating test cases into automated test scripts
Collaborate with peers to identify opportunities for process improvement
Analyze customer field issues and improve Functional test coverage where gaps are identified
Provide extensive documentation to satisfy traceability requirements of FDA approved diagnostic instruments
Develop test specifications and execute them
Provide test results and analysis of test results to the team
Write scripts, set up fixtures, set up equipment as needed for testing
Qualification
Required
Typically requires 0 to 2 years of previous professional experience
Experience writing Python scripts on Linux
Basic understanding of embedded systems
Good verbal and written communication and troubleshooting skills
Working experience with C in embedded systems is highly desirable
Preferred
1-2 years of experience writing automated test scripts on an agile software team
Basic understanding of biology/genetics/NGS preferred, but not required
Experience with Confluence, Jira and Git applications is a plus
Experience with Continuous Integration/Deployment tools also a plus
Benefits
Access to genomics sequencing
Family planning
Health/dental/vision
Retirement benefits
Paid time off
Company
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Funding
Current Stage
Public CompanyTotal Funding
$1.28BKey Investors
Bank of America
2024-09-06Post Ipo Debt· $500M
2023-01-04Post Ipo Debt· $750M
2000-07-28IPO
Leadership Team
Recent News
businessweekly.co.uk
2026-01-11
BioWorld Financial Watch
2026-01-11
Company data provided by crunchbase